Bioequivalence study of two brands of meloxicam tablets in healthy human Pakistani male subjects

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 1, 2011, Pages 115-119

  Ahmad, Mahmood ^a   Murtaza, Ghulam ^b   Akhtar, Naveed ^a   Siddique, Faryal ^a   Khan, Shujaat Ali ^a  

^a THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

^b COMSATS Institute of Information Technology ^*  (Pakistan)

Author keywords

Bioequivalence; Meloxicam; Non compartment model

Indexed keywords

MELFAX; MELOXICAM; UNCLASSIFIED DRUG; XOBIX;

ADULT; ARTICLE; BIOEQUIVALENCE; CROSSOVER PROCEDURE; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OPEN STUDY; PAKISTAN; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SINGLE DRUG DOSE; TABLET;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; CROSS-OVER STUDIES; CYCLOOXYGENASE 2 INHIBITORS; HALF-LIFE; HUMANS; MALE; MODELS, BIOLOGICAL; PAKISTAN; REFERENCE STANDARDS; TABLETS; THERAPEUTIC EQUIVALENCY; THIAZINES; THIAZOLES; YOUNG ADULT;

EID: 79551496159     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bjarnason I, Zanelli G, Prouse P, Smethurst P, Smith T, Levi S, Gumpel MJ, Levi AJ.: Lancet 26, 711 (1987).
2. Busch U., Heinzel G., Narjes H., Nehmiz G.: J. Clin. Pharmacol. 36, 79 (1996).
3. Noble S., Balfour J.A.: Drugs 51, 424 (1996).
4. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., Vane J.R.: Proc. Natl. Acad. Sci. USA 90, 11693 (1993).
5. Engelhardt G., Homma D., Schnitzler C.: Inflamm. Res. 44, 548 (1995).
6. Yocum D., Fleischmann R., Dalgin P., Caldwell J., Hall D., Roszko P.: Arch. Intern. Med. 160, 2947 (2000).
7. Distel M., Mueller C., Bluhmki E., Fries J.: Br. J. Rheumatol. 1, 68 (1996).
8. Turck D., Busch U., Heinzel G., Narjes H.: Arzneimittelforschung 47, 253 (1997).
9. Goei T.H.S., Lund B., Distel M.R., Bluhmki E.: Osteoarthr. Cartil. 5, 283 (1997).
10. Dasandi B., Shivaprakash S.H., Bhat K.M.: J. Pharm. Biomed. Anal. 28, 999 (2002).
11. th edn., Appleton & Lange, Stamford, CT 1999.
12. Nemutlu E., Sayin F., Başci N.E., Kir S.: Hacettepe Univ. J. Fac. Pharm. 27, 107 (2007).
13. Ghorab MM, Salam AHM, Sayad EMA, Mekhel MM.: AAPS PharmSciTech. 5, 63 (2004).
14. Jimenez M.G., Hernandez J.A., Angeles A.P., Contreras L., Garcia A., et al.: Biopharm. Drug Dispos. 26, 167 (2005).
15. Rojanasthien N., Thummati P., Kumsorn B.: Chian. Mai. Med. Bull. 44, 91 (2005).
16. Ziegler L.E., Velicitat P., Bluhmki E., Turck D., Scheuerer S., Combe B.: Inflamm. Res. 1, 5 (2001).